
Accel leads €18m series-B for Doctolib
Venture firm Accel has led an €18m series-B for French doctor booking platform Doctolib alongside existing investors.
The round saw participation from Kerala Ventures, as well as PriceMinister co-founder and CEO Pierre Kosciusko-Morizet, and Bertrand Jelensperger, the co-founder and CEO of LaFourchette.
The Accel-led investment is the third round of funding raised by Doctolib, and brings its total cash raised to €23m.
With the fresh capital in hand, Doctolib plans to roll out its services to major European countries in the coming months, expanding beyond its native France.
Previous funding
Doctolib first raised venture funding in January 2014, when it received a €1m investment from Kerala. A second round followed in November the same year, when Kerala injected a further €4m.
Company
Founded in 2013, Doctolib is a French booking and management software platform for doctors. The company's software-as-a-service product allows patients to book and manage doctor's appointments online, as well as allowing doctors to manage their appointments.
Doctolib claims to reduce booking management costs by 30% and no-show patients by 75%. In France, 5,000 doctors and 100 clinics have signed up for the company's services.
Headquartered in Paris, Doctolib has 15 regional offices across the country.
People
Philippe Botteri is a partner at Accel. Stanislas Niox-Chateau, Ivan Schneider and Jessy Bernal are the co-founders of Doctolib.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater